Recently in Pharma Category

Ethan A. Huff, Natural News
Waking Times

The flow of science in this modern age is largely controlled by just six corporate publishing groups, which by calculated design have been gobbling up the journal market since at least the 1970s. And a new study out of Canada reveals that this mass consolidation of publishing power is, to a large extent, skewing what passes as scientific progress.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

CDC Scientist: ‘We scheduled meeting to destroy vaccine-autism study documents’

A current Centers for Disease Control (CDC) senior scientist has made an unprecedented admission: he and his colleagues–he says– committed scientific misconduct to cover up a meaningful link between vaccines and autism in black boys.

Just as startling, the CDC scientist, Dr. William Thompson, says the study co-authors “scheduled a meeting to destroy documents related to the study. The remaining four co-authors all met and brought a big garbage can into the meeting room, and reviewed and went through all the hardcopy documents that we had thought we should discard, and put them into a huge garbage can.”

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

REP. Bill Posey Calling for an Investigation of the CDC's MMR reasearch fraud


Rep. Bill Posey brings former CDC researcher and now Whistleblower, Dr. Bill Thompson's letter regarding significant files they omitted and destroyed to avoid reporting any significant race effects in their study.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens

  • Andrew F. Read ,
  • Susan J. Baigent,
  • Claire Powers,
  • Lydia B. Kgosana,
  • Luke Blackwell,
  • Lorraine P. Smith,
  • David A. Kennedy,
  • Stephen W. Walkden-Brown,
  • Venugopal K. Nair
  • Published: July 27, 2015
  • DOI: 10.1371/journal.pbio.1002198

Abstract

Could some vaccines drive the evolution of more virulent pathogens? Conventional wisdom is that natural selection will remove highly lethal pathogens if host death greatly reduces transmission. Vaccines that keep hosts alive but still allow transmission could thus allow very virulent strains to circulate in a population. Here we show experimentally that immunization of chickens against Marek's disease virus enhances the fitness of more virulent strains, making it possible for hyperpathogenic strains to transmit. Immunity elicited by direct vaccination or by maternal vaccination prolongs host survival but does not prevent infection, viral replication or transmission, thus extending the infectious periods of strains otherwise too lethal to persist. Our data show that anti-disease vaccines that do not prevent transmission can create conditions that promote the emergence of pathogen strains that cause more severe disease in unvaccinated hosts.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Recently headlines were made as 118 oncologist, of the 22,125 currently active in the United States, sounded the alarm publicly about the rising price of cancer drugs calling them “unsustainable.” This rebellious 118, or half of one percent, appear to be making a valid argument from within a tightly controlled and highly profitable cancer industry. Perhaps unaware to most oncologist and others within the mainstream medical system is that drug companies rely on fraud and half truths to circulate their products. In fact, most major drug companies have repeatedly shown that profit margins trump empathy, true healing and human life 8 days a week.

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

While vaccines for mumps, rubella and measles protect those who are vaccinated and prevent them infecting others, new jabs leave a risk of infecting others

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

The following open letter by a PhD Immunologist completely demolishes the current California legislative initiative to remove all vaccine exemptions. That such a draconian and cynical state statute is under consideration in the ‘Golden State’ is as shocking as it is predictable. After all, it was mysteriously written and submitted shortly after the manufactured-in-Disneyland measles ‘outbreak’.


1497679_688807601160188_503807378_n.jpg

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Impact News Editor Comments

Dr. MaryAnne Demasi’s documentary on the criminal activity of the pharmaceutical industry regarding cholesterol-lowering statin drugs sent shock waves through the mainstream media in Australia last year. Published in two parts on the popular news show The Catalyst, the pharmaceutical industry complained loudly after the first show, and requested the network not air the second episode, “Heart of the Matter Part 2 – Cholesterol Drug War.”

ABC Australia aired it anyway, but the pharmaceutical influence is apparently too strong, as it was announced that the network would remove the videos from their website because “they breached its impartiality standards.” They also removed them from YouTube.


  • Currently 5/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 5/5 (1 votes cast)

Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage

Sandra Waaijenborg1,3, Susan J. M. Hahné1, Liesbeth Mollema1, Gaby P. Smits2, Guy A. M. Berbers2, Fiona R. M. van der Klis2, Hester E. de Melker1, Jacco Wallinga1


Correspondence: Sandra Waaijenborg, PhD, National Institute of Public Health and the Environment, Centre for Infectious Disease Control, Epidemiology and Surveillance Unit, PO Box 1, 3720 BA Bilthoven, the Netherlands (sandra.waaijenborg@rivm.nl).
Presented in part: European Society for Pediatric Infectious Diseases, The Hague, the Netherlands (poster) June 2011. Partly presented as a poster at the Nordic Vaccine meeting, Copenhagen, 5–7 September 2012.
  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

The global market for cancer drugs has hit $100 billion in annual sales, and could reach $147 billion by 2018, according to a new report by the IMS Institute for Healthcare Informatics, a unit of drug data provider IMS Health.

This figure does not include discounts or rebates paid to insurers and government programs; IMS says that in the case of cancer drugs, this should not make a big difference the overall figure.

1.png

  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)

Health Supreme News

Loading...
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Other sites of ours